Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
SEC Filings
Filing date | Form | Description | Filing Group | View |
---|---|---|---|---|
CT ORDER |
CT ORDER |
Other
|
||
UPLOAD |
UPLOAD |
Other
|
||
DRS |
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy |
Registration Statements
|
||
4 |
Statement of changes in beneficial ownership of securities |
3,4,5
|
||
4 |
Statement of changes in beneficial ownership of securities |
3,4,5
|
||
8-K |
Report of unscheduled material events or corporate event |
Current Reports
|
||
S-8 |
Securities offered to employees pursuant to employee benefit plans |
Registration Statements
|
||
10-K |
Annual report which provides a comprehensive overview of the company for the past year |
Annual Filings
|
||
SC 13G/A |
An amendment to the SC 13G filing |
Other
|
||
SC 13G |
A statement of beneficial ownership of common stock by certain persons |
Other
|
Displaying 411 - 420 of 500 results
Data provided by Kaleidoscope.